Marilyn C. Nelson - Mar 25, 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Marilyn Carlson Nelson
Stock symbol
INSP
Transactions as of
Mar 25, 2022
Transactions value $
-$3,825,076
Form type
4
Date filed
3/29/2022, 08:24 PM
Previous filing
Jan 12, 2022
Next filing
Apr 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Sale -$645K -2.58K -2.55% $250.01 98.6K Mar 25, 2022 See Footnote F1, F2, F3
transaction INSP Common Stock Sale -$581K -2.32K -2.36% $250.00 96.2K Mar 28, 2022 See Footnote F1, F3
transaction INSP Common Stock Sale -$1.28M -5K -5.2% $255.00 91.2K Mar 29, 2022 See Footnote F1, F3, F4
transaction INSP Common Stock Sale -$1.3M -5K -5.48% $260.01 86.2K Mar 29, 2022 See Footnote F1, F3, F5
transaction INSP Common Stock Sale -$24.5K -98 -0.11% $250.00 86.1K Mar 29, 2022 See Footnote F1, F3
holding INSP Common Stock 3.71K Mar 25, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.165. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.00 to $255.035. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.08. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney